Published in Int J Radiat Oncol Biol Phys on June 01, 1990
Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg (2003) 2.21
The impact of surgery and mild hyperthermia on tumor response and angioneogenesis of malignant melanoma in a rat perfusion model. BMC Cancer (2004) 0.77
A genomics approach to identify susceptibilities of breast cancer cells to "fever-range" hyperthermia. BMC Cancer (2014) 0.75
Borders of multiple visual areas in humans revealed by functional magnetic resonance imaging. Science (1995) 12.98
Functional mapping of the human visual cortex by magnetic resonance imaging. Science (1991) 6.93
Object-related activity revealed by functional magnetic resonance imaging in human occipital cortex. Proc Natl Acad Sci U S A (1995) 5.98
Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell (1994) 5.79
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer (1994) 5.63
Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms. Cell (1993) 5.47
National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst (2001) 5.09
Perfusion imaging with NMR contrast agents. Magn Reson Med (1990) 5.01
Functional analysis of human MT and related visual cortical areas using magnetic resonance imaging. J Neurosci (1995) 4.77
Accurate quantitation of protein expression and site-specific phosphorylation. Proc Natl Acad Sci U S A (1999) 4.76
Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature (1992) 4.46
The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection. Infect Immun (2000) 3.50
Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer (1998) 3.32
Modular peptide recognition domains in eukaryotic signaling. Annu Rev Biophys Biomol Struct (1997) 3.14
Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn Reson Med (1993) 3.01
MR contrast due to microscopically heterogeneous magnetic susceptibility: numerical simulations and applications to cerebral physiology. Magn Reson Med (1991) 2.75
Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists. Cell (1999) 2.51
Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res (1994) 2.46
Visual motion aftereffect in human cortical area MT revealed by functional magnetic resonance imaging. Nature (1995) 2.33
Comparison of atenolol and propranolol during insulin-induced hypoglycaemia. Br Med J (1976) 2.25
Identification of the binding site for acidic phospholipids on the pH domain of dynamin: implications for stimulation of GTPase activity. J Mol Biol (1996) 2.23
Production of equine infectious anemia antigen in a persistently infected cell line. Arch Gesamte Virusforsch (1973) 2.19
Functional cerebral imaging by susceptibility-contrast NMR. Magn Reson Med (1990) 2.14
A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J (1995) 2.10
The main-chain dynamics of the dynamin pleckstrin homology (PH) domain in solution: analysis of 15N relaxation with monomer/dimer equilibration. J Mol Biol (1997) 1.95
Expression and distribution of leptospiral outer membrane components during renal infection of hamsters. Infect Immun (1999) 1.90
Cellular responses to combinations of hyperthermia and radiation. Radiology (1977) 1.85
Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B. J Clin Oncol (1994) 1.77
Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk. Structure (1995) 1.76
Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology (1990) 1.75
Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med (1988) 1.72
Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B. J Natl Cancer Inst (1996) 1.70
Enhanced resolution of proton NMR spectra of malignant lymph nodes using magic-angle spinning. Magn Reson Med (1996) 1.63
Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. European Working Group on Clinical Cell Analysis. Cytometry (2000) 1.63
Potential hazards and artifacts of ferromagnetic and nonferromagnetic surgical and dental materials and devices in nuclear magnetic resonance imaging. Radiology (1983) 1.62
A novel, specific interaction involving the Csk SH3 domain and its natural ligand. Nat Struct Biol (2001) 1.60
Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer (1999) 1.53
Three-dimensional solution structure of the src homology 2 domain of c-abl. Cell (1992) 1.53
The role of ferritin and hemosiderin in the MR appearance of cerebral hemorrhage: a histopathologic biochemical study in rats. AJNR Am J Neuroradiol (1990) 1.53
Direct determination of changes of interdomain orientation on ligation: use of the orientational dependence of 15N NMR relaxation in Abl SH(32). Biochemistry (1999) 1.51
Socioeconomic status and cancer survival. J Clin Oncol (1991) 1.48
Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders. Clin Lab Haematol (2002) 1.46
Laboratory control of immunocytochemistry. Eur J Haematol (1989) 1.42
Commentary on drug-eluting stents: NICE technology appraisal guidance. Heart (2008) 1.41
Performance evaluation of the FACSCount System: a dedicated system for clinical cellular analysis. Cytometry (1996) 1.40
Serial magnetic resonance imaging in patients following acute myocardial infarction. Magn Reson Imaging (1991) 1.39
Ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia: NICE technology appraisal guidance. Heart (2008) 1.37
Chemical ligation of folded recombinant proteins: segmental isotopic labeling of domains for NMR studies. Proc Natl Acad Sci U S A (1999) 1.36
The affinity-labeling of partially purified acetylcholine receptor from electric tissue of Electrophorus. Proc Natl Acad Sci U S A (1973) 1.34
Projective imaging of pulsatile flow with magnetic resonance. Science (1985) 1.32
A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. Radiology (1993) 1.32
Acebutolol, atenolol, and propranolol and metabolic responses to acute hypoglycaemia in diabetics. Br Med J (1977) 1.29
Flow cytometric quantitation of immunofluorescence intensity: problems and perspectives. European Working Group on Clinical Cell Analysis. Cytometry (1998) 1.28
Family protective factors among urban African American youth. J Clin Child Psychol (1999) 1.28
MR of hemorrhage: a new approach. AJNR Am J Neuroradiol (1986) 1.27
The effect of androgen deprivation and radiation therapy on an androgen-sensitive murine tumor: an in vitro and in vivo study. Cancer J Sci Am (1997) 1.26
Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. Radiology (1992) 1.25
The effect of changes in lactate uptake on the intracellular pH of the perfused rat liver. Clin Sci (1971) 1.24
Sex with children is abuse: Comment on Rind, Tromovitch, and Bauserman (1998). Psychol Bull (2001) 1.23
Solution structure of pleckstrin homology domain of dynamin by heteronuclear NMR spectroscopy. Proc Natl Acad Sci U S A (1995) 1.22
Relationship of Beck Depression Inventory factors to depression among adolescents. J Affect Disord (1997) 1.22
Principles of nuclear magnetic resonance imaging. Radiology (1982) 1.21
Anaphylaxis after oral penicillin. Br Med J (1978) 1.21
NMR imaging of intracranial hemorrhage. J Comput Assist Tomogr (1984) 1.20
Affinity and specificity requirements for the first Src homology 3 domain of the Crk proteins. EMBO J (1995) 1.19
Cardiac susceptibility artifacts arising from the heart-lung interface. Magn Reson Med (2001) 1.19
Magnetic resonance imaging: present and future applications. Can Med Assoc J (1985) 1.16
Myocardial fiber shortening in humans: initial results of MR imaging. Radiology (2000) 1.15
Involving family members in cancer care: focus group considerations of patients and oncological providers. Psychooncology (2000) 1.15
Endocrine dysfunction in Kearns-Sayre syndrome. Clin Endocrinol (Oxf) (1992) 1.14
Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis. Cytometry (1998) 1.14
Magnetic resonance imaging of the heart: positioning and gradient angle selection for optimal imaging planes. AJR Am J Roentgenol (1984) 1.14
Simulated and NMR-derived backbone dynamics of a protein with significant flexibility: a comparison of spectral densities for the betaARK1 PH domain. J Am Chem Soc (2001) 1.13
Response of cells to hyperthermia under acute and chronic hypoxic conditions. Cancer Res (1979) 1.13
Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system. Radiology (1987) 1.12
Coded-aperture imaging of the heart. J Nucl Med (1980) 1.11
Solution structure and dynamics of the bioactive retroviral M domain from Rous sarcoma virus. J Mol Biol (1998) 1.11
Radiation sensitivity of cultured human glioblastoma cells. Radiology (1977) 1.10
Trapping of dextran-coated colloids in liposomes by transient binding to aminophospholipid: preparation of ferrosomes. Biochim Biophys Acta (1994) 1.10
The solution structure of the pleckstrin homology domain of human SOS1. A possible structural role for the sequential association of diffuse B cell lymphoma and pleckstrin homology domains. J Biol Chem (1997) 1.10
Biological and clinical aspects of hyperthermia in cancer therapy. Am J Clin Oncol (1988) 1.09
Evaluation of Gaucher disease using magnetic resonance imaging. J Bone Joint Surg Am (1986) 1.09
Measurement of human myocardial perfusion by double-gated flow alternating inversion recovery EPI. Magn Reson Med (1999) 1.09
Shape of the myopic eye as seen with high-resolution magnetic resonance imaging. Optom Vis Sci (1992) 1.08
Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms. Cancer (1994) 1.08
Central pontine myelinolysis: demonstration by nuclear magnetic resonance. Neurology (1984) 1.08
The use of a calcium-channel blocker, nicardipine, for severely asphyxiated newborn infants. Dev Med Child Neurol (1990) 1.08
Nuclear magnetic resonance relaxation in determination of residue-specific 15N chemical shift tensors in proteins in solution: protein dynamics, structure, and applications of transverse relaxation optimized spectroscopy. Methods Enzymol (2001) 1.06
Value of T1 and T2 relaxation times from echoplanar MR imaging in the characterization of focal hepatic lesions. AJR Am J Roentgenol (1993) 1.05
Preclinical evaluation and phase I clinical trial of a 99mTc-labeled synthetic polymer used in blood pool imaging. AJR Am J Roentgenol (1998) 1.05
Affordable CD4+ T cell counts by flow cytometry. II. The use of fixed whole blood in resource-poor settings. J Immunol Methods (2001) 1.05
The origin of multiple quadrupole couplings in the deuterium NMR spectra of the 2 chain of 1,2 dipalmitoyl-sn-glycero-3-phosphorylcholine. FEBS Lett (1981) 1.05
The solution structure of Abl SH3, and its relationship to SH2 in the SH(32) construct. Structure (1995) 1.04
Effect of clofibrate on glucose tolerance in maturity onset diabetes. Br J Clin Pharmacol (1977) 1.04
Quality of life and survival: the role of multidimensional symptom assessment. Cancer (1998) 1.03
Porcine coronary imaging in vivo by optical coherence tomography. Acta Cardiol (2000) 1.03
Rescuing a destabilized protein fold through backbone cyclization. J Mol Biol (2001) 1.03